Skip to main content
OpenTrials

Clinical trial condition

Previously Untreated Systematically NSCLC

Explore clinical trials studying Previously Untreated Systematically NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Previously Untreated Systematically NSCLC trial results

Recruiting

A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations

NCT06735391

Conditions
Harboring EGFR Sensitive Mutations NSCLC, Locally Advanced or Metastatic Non-squamous NSCLC, Previously Untreated Systematically NSCLC
Locations
  • Sun Yat sen University Cancer Prevention and Treatment Center Guangzhou, China
View Trial Details

Related conditions